What is the nature of the tax issue Medtronic is settling?

The tax issue relates to historical intercompany debt disputes for audit cycles from 1997 to 2007, which Medtronic inherited as a successor to Covidien under a Tax Sharing Agreement.

What is Medtronic's expected financial impact from this settlement?

Medtronic does not expect to recognize any additional charges or impact its reported earnings, as the company had previously set aside adequate reserves to cover its portion of the settlement. Any material non-cash gain will be excluded from non-GAAP earnings.

How much will Medtronic have to pay as part of this settlement?

Medtronic's share is approximately 42% of the total payment to the IRS by the Tax Sharing Participants. The total payment is estimated between $475 million and $525 million, meaning Medtronic's portion would be roughly between $199.5 million and $220.5 million.

When is the payment expected to be made?

The Tax Sharing Participants expect to make the payment to the IRS and among themselves within the next six months from the filing date of this report (January 19, 2016).

MDT 8-K SEC Disclosure — Jan 19, 2016

Summary

This 8-K filing from Medtronic plc (MDT) on January 19, 2016, addresses a significant tax settlement related to its acquisition of Covidien. The company, as a successor to Covidien under a Tax Sharing Agreement, is involved in resolving tax disputes with the IRS concerning intercompany debt for audit cycles spanning 1997-2007. A tentative resolution has been reached that, if finalized, would involve a total cash payment of $475 million to $525 million by the participants to the IRS, including interest and penalties. Medtronic's share of this payment is estimated at 42%, which translates to approximately $199.5 million to $220.5 million. Importantly, the company stated that it does not anticipate recognizing any additional charges, as sufficient reserves have already been established for this controversy. This means the settlement, while substantial, is not expected to impact earnings from an accounting perspective. The Tax Sharing Participants anticipate making the payment within the next six months, and Medtronic has indicated that any material non-cash gain resulting from final adjustments would be excluded from non-GAAP earnings.

Key Highlights

1Medtronic is involved in a tentative settlement with the IRS regarding historical tax issues dating back to 1997-2007, stemming from its acquisition of Covidien.
2The settlement involves resolving disputes related to intercompany debt before the U.S. Tax Court and the IRS Appeals Division.
3The total cash payment to the IRS by all Tax Sharing Participants is estimated to be between $475 million and $525 million, inclusive of interest and penalties.
4Medtronic's proportionate share of this payment is approximately 42%, ranging from $199.5 million to $220.5 million.
5The company expects no additional charges, as it had previously recorded sufficient reserves to cover its obligations under the settlement.
6Final resolution and payment are anticipated within the next six months.
7Any material non-cash gain from final adjustments will be excluded from Medtronic's non-GAAP earnings.

Medtronic plc 8-K Report, Corporate Update (Jan 19, 2016)

Summary

Key Highlights

Frequently Asked Questions